Coordinating partners
With the help of improved prevention, earlier detection, more effective treatments and functioning rehabilitation, no one should have to die from cancer in the future. And the road to that vision is via new cross-border partnerships and a systematic investment in innovation.
Coordinating partners
Vinnova-funded Vision Zero Cancer – established in 2019 – currently brings together a number of stakeholders from the healthcare and medical world, academia, the pharmaceutical and medtech industry and is continuously entering into new partnerships.
Vision Zero Cancer is a Swedish research- and innovation milieu that engages actors across society in strategic actions to work jointly in the mission of beating cancer. The founders are the Confederation of Regional Cancer Centres at the Swedish Association of Local Authorities and Regions, Stockholm School of Economics, AstraZeneca and Elekta. It is managed as a partnership, led by an office at House of Innovation, Stockholm School of Economics.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical business and their innovative medicines are used by millions of patients worldwide. Driven by innovative science and an entrepreneurial culture, they are focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.
Elekta
Through precision radiation medicine, Elekta is helping clinicians focus where it matters, empowering them to protect the moments that matter for their patients. They are committed to ensuring everyone with cancer in the world has access to – and benefits from – more precise, personalized radiotherapy treatments.
Karolinska Institutet
Karolinska Institutet är ett av världens ledande medicinska universitet. Universitetets webbplats vänder sig till studenter, forskare, medarbetare, samarbetspartners och till dig som vill veta mer om medicinsk forskning och utbildning.
Karolinska Universitetssjukhuset
Karolinska Universitetssjukhuset är ett av Europas ledande sjukhus med ett uppdrag att bedriva och utveckla sjukvård, forskning och utbildning. På vår webbplats kan du som är patient, närstående, vårdgivare, forskare eller arbetssökande läsa mer om vår högspecialiserade vård.
Confederation of Regional Cancer Centres
Regional Cancer Centres (RCC) work together at national level to create a more equal cancer care in the whole country together with the six healthcare regions – North, Stockholm Gotland, South, Southeast, Mid-Sweden and West.
Roche
Roche is a global pioneer in healthcare and was one of the first companies to bring targeted treatment to patients. Their purpose is to do now what the patient needs next. The combined strength of medicines and diagnostics under one roof has given Roche a leading role in precision medicine.
Stockholm School of Economics
The Stockholm School of Economics is an academic hub for ambitious students and researchers from all over the world. By working closely with corporate partners and society at large, SSE has been creating opportunities for its graduates for over 100 years. They conduct research and education in economics, finance, business administration and related disciplines.
Swedish association of Local Authorities and Regions
The Swedish Association of Local Authorities and Regions (SALAR) is an employers’ organisation and an organisation that represents and advocates local government in Sweden. All of Sweden’s municipalities and regions are members of SALAR.
Our story
On 14 May 2019, a group of people from different backgrounds and competences gathered. All with a common drive to ensure that many more survive cancer and fewer to fall ill. That meeting was the first step in forming Vision Zero Cancer – a Swedish milieu for system innovation.
Sweden has come a long way in regards of cancer care. In 2009 Sweden adopted a national cancer strategy. The strategy set up six regional cancer centers for fostering development and knowledge in the six healthcare regions. This kick-started the development of more patient-focused, accessible and equitable cancer care. National care programs, standardized care processes, contact nurses, the concentration of highly specialized treatments and new therapies have been developed and introduced into cancer care. But there are still challenges – and opportunities.
When Professor Dr. Hans Hägglund took over as the national cancer coordinator for the Government in March 2019, he saw a need to strengthen cooperation to better integrate cancer research and innovation into healthcare. He extended invitations to the meeting that later became the starting point of Vision Zero Cancer. A meeting between people from different backgrounds and competences, disciplines, and industries. All wanting to move from today’s isolated initiatives to greater cooperation. All driven by the same vision – that no one should die because of cancer and that more people should live longer and better.
16 people from 14 actors applied to Vinnova’s call for vision-driven health:
Anders Blanck, LIF – Swedish Association of the Pharmaceutical Industry
Bengt Bergman, SLUSG, Sahlgrenska University Hospital and Sahlgrenska Academy
Björn Arvidsson, STUNS Life Science
Ebba Carbonnier, Swelife
Ebba Hallersjö Hult, Head of Vision Zero Cancer
Hans Hägglund, National Cancer Coordinator Swedish Association of Local Authorities and Regions and chairman of the Confederation of Regional Cancer Centres
Hans Winberg, Leading Health Care
Karin Elinder, Swedish Cancer Society
Lena Svendsen, Swedish Medtech
Magnus Mähring, Stockholm School of Economics, House of Innovation
Matz Larsson, Clinical Centre for Health Promotion at the University of Lund
Mia Rajalin, Swedish Patient Association for Lung Cancer
Per Nylund, Elekta
Ola Ejlertsson, Stockholm School of Economics Executive Education
Simon Ekman, SLUSG, Karolinska University Hospital and Karolinska Institutet
Suzanne Håkansson, AstraZeneca